Since expressing Glo1 in the hearts of T1DM rats attenuated MG accumulation, it was not surprising that it also blunted NF-κB (p-65 subunit) activation and tumor necrosis factor alpha (TNF-α), since MG is an activator of NF-κB [25]. This evidence concerns the gene GLO1 and myasthenia gravis.